Merck & Company Inc (MRK)
Gross profit margin
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Gross profit | US$ in thousands | 36,044,000 | 30,592,000 | 27,923,000 | 23,093,000 | 18,184,000 |
Revenue | US$ in thousands | 64,168,000 | 60,115,000 | 59,283,000 | 48,704,000 | 41,518,000 |
Gross profit margin | 56.17% | 50.89% | 47.10% | 47.41% | 43.80% |
December 31, 2024 calculation
Gross profit margin = Gross profit ÷ Revenue
= $36,044,000K ÷ $64,168,000K
= 56.17%
Based on the data provided, Merck & Company Inc's gross profit margin has shown a positive trend over the years. The gross profit margin increased from 43.80% as of December 31, 2020, to 56.17% as of December 31, 2024. This indicates that the company has been able to effectively manage its cost of goods sold relative to its sales revenue, resulting in a higher percentage of revenue retained as gross profit.
The steady improvement in the gross profit margin reflects Merck & Company Inc's ability to maintain pricing power, control production costs, or enhance product mix. A rising gross profit margin is generally considered a positive indicator of a company's operational efficiency and profitability.
It is worth noting that the significant increase in the gross profit margin from 2023 to 2024, jumping from 50.89% to 56.17%, indicates a notable performance improvement within the company's operations during that period. This suggests that Merck & Company Inc may have implemented strategic initiatives that positively impacted its gross profitability.
Overall, the increasing trend in Merck & Company Inc's gross profit margin demonstrates the company's ability to generate more gross profit from its sales over time, which is a favorable sign for investors and stakeholders.
Peer comparison
Dec 31, 2024